{"id":"W2037559535","doi":"10.1097/cco.0b013e3282f335a3","title":"Epidermal growth factor receptor inhibitors in the treatment of lung cancer: reality and hopes","year":2008,"lang":"en","type":"review","venue":"Current Opinion in Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Exelixis","keywords":"Erlotinib; Gefitinib; Medicine; Lung cancer; Epidermal growth factor receptor; Tyrosine kinase; Erlotinib Hydrochloride; Tyrosine-kinase inhibitor; Monoclonal antibody; Docetaxel; Cancer research; Bevacizumab; EGFR inhibitors; Clinical trial; Oncology; Pharmacology; Cancer; Internal medicine; Receptor; Antibody; Immunology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001019345,0.0008708307,0.00191388,0.001605226,0.0002574508,0.001033104,0.001042132,0.001449736,0.003564934],"category_scores_gemma":[0.00094292,0.0002414944,0.0005513728,0.002296071,0.0004789278,0.001851825,0.0004791887,0.002021431,0.003384621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006491403,"about_ca_system_score_gemma":0.001126687,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008509719,"about_ca_topic_score_gemma":0.001888177,"domain_scores_codex":[0.9997583,0.00005387975,0.00003350253,0.00002806878,0.0001056457,0.00002072536],"domain_scores_gemma":[0.9995142,0.0002072942,0.00008683283,0.00001125592,0.0001237534,0.00005661026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001194152,0.00005948083,0.0001497267,0.0162008,0.0001226842,0.0002705402,0.00005084382,0.0003602196,0.0009307935,0.002460177,0.08352018,0.8957551],"study_design_scores_gemma":[0.00004960117,0.0001166211,0.0007712076,0.007108185,0.0001601,0.001748808,0.00008921852,0.0001043968,0.0002124854,0.001876527,0.9877457,0.00001716942],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005240602,0.9984584,0.00005377409,0.000541758,0.0003219892,0.000003027172,0.000006443245,0.000005160021,0.000557167],"genre_scores_gemma":[0.0002724733,0.9985743,0.0001121881,0.0003471115,0.000324301,0.000003842911,0.00001198974,0.000001087851,0.0003527719],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003564934,"threshold_uncertainty_score":0.01192588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1319367048533914,"score_gpt":0.5022138484156957,"score_spread":0.3702771435623043,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}